STEADY-STATE CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND DESMETHYLMIANSERIN IN POOR AND IN HOMOZYGOUS AND HETEROZYGOUS EXTENSIVE METABOLIZERS OF DEBRISOQUINE
Cb. Eap et al., STEADY-STATE CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND DESMETHYLMIANSERIN IN POOR AND IN HOMOZYGOUS AND HETEROZYGOUS EXTENSIVE METABOLIZERS OF DEBRISOQUINE, Therapeutic drug monitoring, 20(1), 1998, pp. 7-13
Steady state concentrations of (S)- and (R)-mianserin and desmethylmia
nserin were measured in 21 homozygous extensive metabolizers (as deter
mined by genotyping for mutations 3 [or A] and 4 [or B]), in seven het
erozygous extensive metabolizers and in one poor metabolizer of debris
oquine, as well as in one patient receiving very high doses of mianser
in (360 mg/day) and fluoxetine (160 mg/day), a strong cytochrome P450I
ID6 inhibitor. The mean dose of mianserin was (mean +/- SD, range: 67
+/- 63, 10 to 360 mg/day). High dispersions of the (S)/(R)-mianserin a
nd desmethylmianserin ratios were observed (mean +/- SD, range: 2.10 /- 1.01, 0.64 to 4.76, and 0.29 +/- 0.14, 0.08 to 0.57, respectively).
The highest (S)/(R)-mianserin ratio was calculated for the poor metab
olizer (4.76) agreeing with those results of a single-dose study with
poor and extensive metabolizers of debrisoquine, in that the cytochrom
e P450IID6 is probably involved in the metabolism of mianserin with an
enantioselectivity for the (S)-enantiomer. Nevertheless, the mean con
centration-to-dose ratios for (S)- or (R)-mianserin or desmethylmianse
rin were not significantly different between homozygous and heterozygo
us extensive metabolizers, and no particular values were measured in t
he poor metabolizer nor in the patient receiving fluoxetine. Furthermo
re, the (S)/(R)-mianserin ratio measured in the PM was only slightly h
igher than the second highest ratio (3.85) of an homozygous extensive
metabolizer, whereas no particular value (2.92) was calculated for the
patient taking fluoxetine. Finally, no significant differences in (S)
/(R)-mianserin or (S)/(R)-desmethylmianserin were calculated between h
omozygous and heterozygous extensive metabolizers. Although the number
of patients included in this study is too low to allow definite concl
usions, the results suggest that the debrisoquine genotype has only a
moderate influence on the steady state concentrations of the enantiome
rs of mianserin and desmethylmianserin.